Authors:
LORUSSO V
POLLERA CF
ANTIMI M
LUPORINI G
GRIDELLI C
FRASSINETI GL
OLIVA C
PACINI M
DELENA M
Citation: V. Lorusso et al., A PHASE-II STUDY OF GEMCITABINE IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT PREVIOUSLY TREATED WITH PLATINUM, European journal of cancer, 34(8), 1998, pp. 1208-1212
Citation: Cf. Pollera, MORE IS BETTER BUT .... HOW IS BEST - ARE MILLIGRAMS OVER HOURS BETTER THAN GRAMS OVER MINUTES - THE CASE OF GEMCITABINE, Journal of clinical oncology, 15(5), 1997, pp. 2172-2173
Authors:
POLLERA CF
CERIBELLI A
CRECCO M
OLIVA C
CALABRESI F
Citation: Cf. Pollera et al., PROLONGED INFUSION GEMCITABINE - A CLINICAL-PHASE-I STUDY AT LOW (300MG M(2)) AND HIGH-DOSE (875 MG/M(2)) LEVELS/, Investigational new drugs, 15(2), 1997, pp. 115-121
Authors:
NARDI M
DELLAGIULIA M
POLLERA CF
MAROLLA P
RUGGERI EM
IACOVELLI A
ATLANTE G
CALABRESI F
Citation: M. Nardi et al., A COMBINATION OF IFOSFAMIDE AND MITOXANTRONE AS SALVAGE THERAPY IN PATIENTS WITH ADVANCED OVARIAN-CANCER, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 298-301
Authors:
POLLERA CF
CERIBELLI A
CRECCO M
CALABRESI F
Citation: Cf. Pollera et al., WEEKLY GEMCITABINE IN ADVANCED BLADDER-CANCER - A PRELIMINARY-REPORT FROM A PHASE-I STUDY, Annals of oncology, 5(2), 1994, pp. 182-184
Authors:
POLLERA CF
CALABRESI F
MORESCHI M
RUGGERI EM
GIANNARELLI D
MASCIULLI R
TESTA U
PESCHLE C
Citation: Cf. Pollera et al., HIGH DOSE-INTENSE CHEMOTHERAPY ALONE OR IN COMBINATION WITH INTERLEUKIN-2 FOR SMALL-CELL LUNG-CANCER - A PILOT-STUDY, Cancer investigation, 12(6), 1994, pp. 574-587
Authors:
POLLERA CF
CERIBELLI A
CRECCO M
CALABRESI F
Citation: Cf. Pollera et al., WEEKLY GEMCITABINE IN ADVANCED OR METASTATIC SOLID TUMORS - A CLINICAL-PHASE-I STUDY, Investigational new drugs, 12(2), 1994, pp. 111-119
Citation: Cf. Pollera, APPROVED DRUGS FOR UNLABELED USES - NATIONAL-HEALTH COST-CONTAINMENT DENIES ACCESS TO STATE-OF-THE-ART CANCER THERAPIES IN ITALY, Annals of oncology, 4(8), 1993, pp. 701-702